Page last updated: 2024-08-25

epristeride and Urinary Bladder Neoplasms

epristeride has been researched along with Urinary Bladder Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chan, CK; Chan, LW; Chan, SF; Chan, SY; Cheng, CW; Cheung, HY; Lai, FM; Li, ML; Ng, CF; To, KF; Wong, WS1

Trials

1 trial(s) available for epristeride and Urinary Bladder Neoplasms

ArticleYear
Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
    International journal of urology : official journal of the Japanese Urological Association, 2005, Volume: 12, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Androstadienes; BCG Vaccine; Carcinoma, Transitional Cell; Cross-Over Studies; Cystectomy; Cystoscopy; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms

2005